Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
•
Primary Care
Is there any reason to stop mesalamine in a patient with UC undergoing breast/regional nodal radiation?
Answer from: Radiation Oncologist at Community Practice
I have run into this situation a few times and have not stopped mesalamine during breast radiation. Have not noticed any issues.
Sign in or Register to read more
11392
Related Questions
What is your preferred method of surveillance after mastectomy?
Do you recommend self-breast exams to your patients with history of breast cancer in addition to imaging surveillance?
How would you treat a patient with HER2 positive CNS only progression on fam-trastuzumab which had previously progressed on tucatinib/capecitabine/trastuzumab, and has failed both SRS and WBRT?
What hotspot and heterogeneity metrics do you utilize when delivering PMRT to a patient who has had breast reconstruction?
Would you consider partial breast irradiation in patients who otherwise meet PBI guidelines who have a pathogenic variant of CHEK2 or other moderate penetrance gene?
How would you approach an isolated supraclavicular nodal recurrence involving the skin in a patient who has received standard chest wall and nodal radiation therapy?
How are you clinically incorporating the data presented from RT Charm at ASTRO 2024?
Is REZUM (water vapor thermotherapy for BPH) safe after EBRT?
What are your top takeaways in Breast Cancer from ASTRO 2024?
When treating chestwall + RNI with VMAT, how much do you crop the PTV into lung as is done with the PTVeval in 3D contouring guides?